FDA puts new limits on Johnson & Johnson vaccine due to rare blood clotting condition
May 05, 2022 at 18:13 PM EDT
The FDA revised its emergency authorization to sharply limit the use of Johnson & Johnson's COVID-19 vaccine due to a rare but potentially fatal blood clotting condition called thrombosis with thrombocytopenia syndrome (TTS).
